FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117886928> ?p ?o ?g. }

• W2117886928 abstract "The speed of flea knockdown by different products and their duration of effectiveness are factors which affect veterinarian prescribing decisions. To further validate the month-long pulicidal effectiveness of spinosad and determine its rate of flea knockdown to that of afoxolaner, three studies were conducted in two laboratories in the United States, utilizing flea infestations from colonies which are regularly refreshed through introduction of locally caught fleas.All study assessors were blinded, dogs were ranked by pre-study flea counts and randomized accordingly, and treatments administered on Day 0. All studies included a negative control group; two also included an afoxolaner group. In one study, flea challenges for treated and control dogs (10 per group) were completed 21 and 28 days after treatment and counts were performed 24 h later. In each of two speed-of-knockdown (SOK) studies, 36 dogs were randomized, six dogs per group, to: untreated controls; administered oral afoxolaner (2.6-6.2 mg/kg); or oral spinosad (32.1-59.2 mg/kg). In the SOK studies, live fleas from Day -1 infestations were counted after being combed off at 1 and 3 h after treatment, and after reinfestations on Day 7.There were no treatment-related adverse events. Spinosad was 98.6% effective at 28 days post treatment. For SOK, geometric mean live flea counts for afoxolaner were not different from controls at any assessment. For spinosad, all mean counts were significantly lower than in controls (p ≤ 0.0128) except at 1 h post treatment in both studies. Spinosad was significantly more effective than afoxolaner in both studies at 3 h post treatment (p ≤ 0.0065) and post-Day 7 infestation (p ≤ 0.0054), and at 1 h post treatment (p = 0.0276) and post-Day 7 infestation in one study.These data validate spinosad's faster onset of flea knockdown than afoxolaner against infestations present at the time of treatment, and faster residual speed of flea knockdown for at least 7 days post treatment, and confirm spinosad's extended residual speed of kill for at least 28 days post treatment." @default.
• W2117886928 created "2016-06-24" @default.
• W2117886928 creator A5003374751 @default.
• W2117886928 creator A5037855376 @default.
• W2117886928 creator A5055367347 @default.
• W2117886928 creator A5074385286 @default.
• W2117886928 date "2015-11-09" @default.
• W2117886928 modified "2023-09-27" @default.
• W2117886928 title "Speed of flea knockdown of spinosad compared to afoxolaner, and of spinosad through 28 days post-treatment in controlled laboratory studies" @default.
• W2117886928 cites W1216384651 @default.
• W2117886928 cites W1514467875 @default.
• W2117886928 cites W1975178417 @default.
• W2117886928 cites W1995739811 @default.
• W2117886928 cites W2018190974 @default.
• W2117886928 cites W2024537378 @default.
• W2117886928 cites W2090219325 @default.
• W2117886928 cites W2106921990 @default.
• W2117886928 cites W2127344574 @default.
• W2117886928 cites W2144474384 @default.
• W2117886928 cites W2152223962 @default.
• W2117886928 cites W5649137 @default.
• W2117886928 doi "https://doi.org/10.1186/s13071-015-1195-5" @default.
• W2117886928 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4640350" @default.
• W2117886928 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26552479" @default.
• W2117886928 hasPublicationYear "2015" @default.
• W2117886928 type Work @default.
• W2117886928 sameAs 2117886928 @default.
• W2117886928 citedByCount "9" @default.
• W2117886928 countsByYear W21178869282017 @default.
• W2117886928 countsByYear W21178869282018 @default.
• W2117886928 countsByYear W21178869282019 @default.
• W2117886928 countsByYear W21178869282021 @default.
• W2117886928 crossrefType "journal-article" @default.
• W2117886928 hasAuthorship W2117886928A5003374751 @default.
• W2117886928 hasAuthorship W2117886928A5037855376 @default.
• W2117886928 hasAuthorship W2117886928A5055367347 @default.
• W2117886928 hasAuthorship W2117886928A5074385286 @default.
• W2117886928 hasBestOaLocation W21178869281 @default.
• W2117886928 hasConcept C161176658 @default.
• W2117886928 hasConcept C2777786777 @default.
• W2117886928 hasConcept C2777875022 @default.
• W2117886928 hasConcept C33070731 @default.
• W2117886928 hasConcept C42972112 @default.
• W2117886928 hasConcept C6557445 @default.
• W2117886928 hasConcept C71924100 @default.
• W2117886928 hasConcept C86803240 @default.
• W2117886928 hasConceptScore W2117886928C161176658 @default.
• W2117886928 hasConceptScore W2117886928C2777786777 @default.
• W2117886928 hasConceptScore W2117886928C2777875022 @default.
• W2117886928 hasConceptScore W2117886928C33070731 @default.
• W2117886928 hasConceptScore W2117886928C42972112 @default.
• W2117886928 hasConceptScore W2117886928C6557445 @default.
• W2117886928 hasConceptScore W2117886928C71924100 @default.
• W2117886928 hasConceptScore W2117886928C86803240 @default.
• W2117886928 hasIssue "1" @default.
• W2117886928 hasLocation W21178869281 @default.
• W2117886928 hasLocation W21178869282 @default.
• W2117886928 hasLocation W21178869283 @default.
• W2117886928 hasLocation W21178869284 @default.
• W2117886928 hasOpenAccess W2117886928 @default.
• W2117886928 hasPrimaryLocation W21178869281 @default.
• W2117886928 hasRelatedWork W1514467875 @default.
• W2117886928 hasRelatedWork W1975178417 @default.
• W2117886928 hasRelatedWork W1996073042 @default.
• W2117886928 hasRelatedWork W2138872065 @default.
• W2117886928 hasRelatedWork W2152223962 @default.
• W2117886928 hasRelatedWork W2162737864 @default.
• W2117886928 hasRelatedWork W2294281787 @default.
• W2117886928 hasRelatedWork W2300900718 @default.
• W2117886928 hasRelatedWork W2746506362 @default.
• W2117886928 hasRelatedWork W2979560452 @default.
• W2117886928 hasVolume "8" @default.
• W2117886928 isParatext "false" @default.
• W2117886928 isRetracted "false" @default.
• W2117886928 magId "2117886928" @default.
• W2117886928 workType "article" @default.